| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/06/1997 | WO1997007785A1 Therapeutic lipidic vesicles: methods of use and compositions |
| 03/06/1997 | WO1997007784A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 03/06/1997 | WO1997007772A1 Compositions containing a peptide cell growth promoter |
| 03/06/1997 | WO1997007769A2 Chemical compounds |
| 03/06/1997 | WO1997007757A1 Bismuth-containing compounds in topical dosage forms |
| 03/06/1997 | WO1997007674A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | WO1997007667A1 Ribozymes targetting hiv and siv |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | WO1997005249A3 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 03/06/1997 | WO1996040768A3 Anti-fungal and anti-bacterial histatin-based peptides |
| 03/06/1997 | WO1996039422A3 Modification of polypeptide drugs to increase electrotransport flux |
| 03/06/1997 | WO1996038093A3 Method for laser mediated tissue welding with enhanced strength |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2230929A1 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | CA2230852A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230671A1 Methods and compositions for the selective modification of nucleic acids |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230209A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | CA2230144A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | CA2229749A1 Chimeric antiviral agents which incorporate rev binding nucleic acids |
| 03/06/1997 | CA2227516A1 Acylated oligopeptide derivatives having cell signal inhibiting activity |
| 03/06/1997 | CA2227278A1 Method and composition for enhanced parenteral nutrition |
| 03/06/1997 | CA2227040A1 Chemical compounds |
| 03/06/1997 | CA2226963A1 Crystalline zap family proteins |
| 03/06/1997 | CA2203768A1 Agent promoting conception |
| 03/06/1997 | CA2203377A1 Method for testing myocarditis or cardiomyopathy |
| 03/06/1997 | CA2202887A1 Oral cyclosporin formulations |
| 03/05/1997 | EP0760376A1 Peptides inhibiting phospholipase c |
| 03/05/1997 | EP0760237A1 Oil-in-water microemulsions |
| 03/05/1997 | EP0760014A1 Identification and use of antiviral compounds |
| 03/05/1997 | EP0760013A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759992A1 Human papilloma virus inhibition by a hairpin ribozyme |
| 03/05/1997 | EP0759990A1 Ribozymes with product ejection by strand displacement |
| 03/05/1997 | EP0759988A1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 03/05/1997 | EP0759987A1 Human restrictin and nucleic acid sequences |
| 03/05/1997 | EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759976A1 The isolation and production of catalytic antibodies using phage technology |
| 03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759940A1 A dna molecule encoding a mast cell function-associated antigen (mafa) |
| 03/05/1997 | EP0759939A1 Methods and compositions for the dry powder formulation of interferons |
| 03/05/1997 | EP0759938A1 Neurogenic differentiation (neurod) genes and proteins |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759936A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 03/05/1997 | EP0759786A1 Somatostatin binding peptide-metal chelate conjugates |
| 03/05/1997 | EP0759782A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
| 03/05/1997 | EP0759781A1 Method for treating and preventing atherosclerosis |
| 03/05/1997 | EP0759777A1 VACCINE FOR $i(MORAXELLA CATARRHALIS) |
| 03/05/1997 | EP0759776A1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 03/05/1997 | EP0759775A1 IFN-$g(b) LIQUID FORMULATIONS |
| 03/05/1997 | EP0759774A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
| 03/05/1997 | EP0759773A1 Lacrimal gland specific emulsions for topical application to ocular tissue |
| 03/05/1997 | EP0759772A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/05/1997 | EP0759771A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759769A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1) |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0759765A1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 03/05/1997 | EP0759764A1 Composition for dental use comprising krill enzyme |
| 03/05/1997 | EP0759762A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0759753A1 Methods and compositions for reducing multidrug resistance |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759748A1 Uses of a vitamin of the k-group against a loss of cognitive faculties |
| 03/05/1997 | EP0759695A1 A method of inducing an immune response using vaccinia virus recombinants |
| 03/05/1997 | EP0759693A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS |
| 03/05/1997 | EP0708877B1 Method for repairing a combustion chamber assembly |
| 03/05/1997 | EP0694036B1 Hydroxamic acid derivatives |
| 03/05/1997 | EP0656064B1 Bispecific immunoadhesins |
| 03/05/1997 | EP0612349B1 Novel thrombin inhibitor protein from reduvii |
| 03/05/1997 | EP0597851B1 Method for preparing interferon alpha-2 crystals |
| 03/05/1997 | EP0586545B1 Electrophoretic display panel with tapered grid insulators and associated methods |
| 03/05/1997 | EP0585300B1 Galanin antagonist |
| 03/05/1997 | EP0584360B1 Wf11243 substance |
| 03/05/1997 | EP0564466B1 Lhrh-antagonists |
| 03/05/1997 | EP0504207B1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it |
| 03/05/1997 | EP0498804B1 A method of preparing a vaccine or toxoid |
| 03/05/1997 | CN1144489A Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 03/05/1997 | CN1144488A Novel remedy for respiratory-tract viral disease |
| 03/05/1997 | CN1144487A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 03/05/1997 | CN1144486A Treatment of ovarian estrogen dependent conditions |
| 03/05/1997 | CN1144482A Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 03/05/1997 | CN1144273A Method for preparation of polypeptide and amino-acid by enzymatic hydrolysis of animal slaughtering blood |
| 03/04/1997 | USH1638 Cyclic hexapeptide |
| 03/04/1997 | US5608078 Phosphonomethyldipeptides and process for preparation thereof |
| 03/04/1997 | US5608072 Retroviral protease inhibiting compounds |
| 03/04/1997 | US5608045 Disodium salt by pot reacting rhamnose triacetate with phenyl dichlorophosphate in presence of triethylamine and with /s/leu-/s/trp-oet in solvent, saponifying separated product with ethanolic base in cold, evaporating ethanol |